Tags |
|
|
Links |
|
|
E-Folder - More Web PR Dilemmas
As public relations find blogs useful in communicating effectively to specific audience, PR is now giving a second thought of actually using blogs as a tool f
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
Blogs, and Public Relations, it shows some of the main concerns of most public relations and media groups. This includes how to connect with bloggers an
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
how to use blogs effectively. This specific concern may already sound outdated, but the underlying issues behind them are very important in the decisions of
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
communication specialists to use blogs as part of their communication tool.
The thought of the so-called “long tail” concept originally coined by d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
The thought of the so-called “long tail” concept originally coined by d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
tp://en.wikipedia.org/wiki/Long_tail" target="_new">Chris Anderson, wherein there are actually few weblogs who have many readers and millions of weblogs w
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
o have few readers on their site. Between these two, however, what most PR thought effective is the weblogs who have few readers. I slightly agree with this o
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
bservation that with few readers on a site, the exchange of ideas and opinions are more focused and significant. It is true in a sense. However, most read blo
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
gs too could create the same healthy discussion room.
As for my own observation, it is not a matter of how little and exclusive a blog is in order to gain a
As for my own observation, it is not a matter of how little and exclusive a blog is in order to gain a
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ignificant exchange of opinions between the blogger and its readers. There are high-traffic sites gain participatory readers. I think what makes them good blo
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
gs, where there is actual communication, is that they blog boldly. They wrap their thoughts in a brief and unique way. These elements trigger visito
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
rs’ attention, which make them participate in the blogger’s monologue.
However, the continuing pull of attention by good bloggers makes blogs for most PR har
However, the continuing pull of attention by good bloggers makes blogs for most PR har
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
to handle when it comes to looking at specific audiences. With most readers participating to almost any blog that catches their attention, it is hard to real
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ly target real interested audience.
Another concern the article pointed is that there is no actual correlation between the number of links to a site and the
Another concern the article pointed is that there is no actual correlation between the number of links to a site and the
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
persistent attention of readers in the site. For example, the article says,
For instance, it’s customary for bloggers to maintain “blogrolls” - l
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
sts of other blogs they’ve read and find interesting, or blogs by people they know - in the margins of their sites. However it doesn’t necessarily follow that
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
a blogger actually reads all the blogs on his blogroll on a regular basis.
This point is true as much as it is also true that the stats on the
This point is true as much as it is also true that the stats on the
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
number of hits and links are not determinants of audience attention. Thus, the problem of actually looking for real influential sites is very hard to do.
As
As
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
iscussed before on metric tools available on the net like traffic web stats, PR can now measure its effectiveness. Yet, presented with these concerns, I think
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
that PR should not rely on web stats alone. There is still the need to look for other ways to make their campaigns not only effective, but also more accurate
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/58374/e-folder-More-Web-PR-Dilemmas.html">More Web PR Dilemmas</a>
BB link (for phorums):
[url=http://www.e-folder.org.ua/article/58374/e-folder-More-Web-PR-Dilemmas.html]More Web PR Dilemmas[/url]
Related Articles:
Recruiting Sales and Marketing Talent in a Full Employment Economy
What Good Leadership Can Mean to Your Business
Bookmark it:
|